In our previous study, we have identified that LYPLAL1-DT facilitates SCLC tumorigenesis and chemoresistance through a ceRNA mechanism involving the miR-204-5p/PFN2 and miR-204-5p/BCL2 axes[15,16,20]. This evidence concerns the gene BCL2 and small cell lung carcinoma.